StockData
FibroBiologics, Inc. logo

FibroBiologics, Inc. (FBLG) stock

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30
$0.70−0.13 (-15.06%)

Close on Nov 20, 2026Market cap $4.69MP/E –Yield –

FibroBiologics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for FibroBiologics

FibroBiologics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More FibroBiologics figures

See a number that looks wrong?